Federal Supply Schedule 36F79721D0216

Award Date 8/15/21
Last Date to Order 8/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Pharmaessentia USA Corp, a foreign-owned for-profit organization. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a ceiling value of $6,000,000.00 and a period of performance from June 1, 2022 to May 31,...
This federal contract IDV award is a Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The contract provides for the delivery of pharmaceutical and drug products, as well as hematology-related products, with a total ceiling value of $444,187.20. The contract was awarded to R-Pharm US LLC, a for-profit manufacturer, on September 1, 2016, with a period of performance through March 31, 2026. The...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs. The contract has an award date of September 29, 2024 and a ceiling value of $225,000.00, with a period of performance through September 28, 2029. The contract is for the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under FSS category 65 I B. The prime contractor is Leading Pharma...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance through July 31, 2025. The prime contractor for this multiple-award FSS contract is Novis PR LLC, doing business as Kramer-Novis. The contract was awarded on March 15, 2018 under the...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), provides for the delivery of drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $174,737,620.00 and a period of performance through March 31, 2028. The prime contractor for this multiple award contract is Kowa Pharmaceuticals America Inc., a for-profit manufacturer of goods. The contract does not utilize any set-asides. The scope of the contract encompasses a...
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides Pharmaceuticals and Drugs (FSS-61-IB) to the agency's Veterans Integrated Service Network 12. The prime contractor, Avion Pharmaceuticals, LLC, was awarded this multiple-award contract with a ceiling value of $675,000.00 and a period of performance through December 31, 2025. The contracted products and services encompass a broad range of pharmaceutical and hematology-related items....

This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule.

The contract has a ceiling value of $1,870,730,000.00 and was awarded to Viiv Healthcare Company, a foreign-owned, for-profit manufacturer of goods. The contract has a period of performance from August 15, 2021 through August 14, 2026. The contract is a multiple award, with no set-aside used. The contracted products and services aim to provide the VA with a wide range of pharmaceutical and hematology-related items needed to support the healthcare of military veterans. Specific task orders and price lists were not provided, but the broad scope indicates the VA is seeking to establish a comprehensive, indefinite delivery vehicle for these critical medical supplies and treatments.

Generated 2/19/25, 9:07 AM